Highly efficient genome editing in primary human bronchial epithelial cells differentiated at air-liquid interface
Eur Respir J
.
2020 May 21;55(5):1900950.
doi: 10.1183/13993003.00950-2019.
Print 2020 May.
Authors
Radu Rapiteanu
1
,
Tina Karagyozova
2
,
Natalie Zimmermann
3
,
Kuljit Singh
2
,
Gareth Wayne
2
,
Matteo Martufi
2
,
Nikolai N Belyaev
3
,
Edith M Hessel
3
,
David Michalovich
3
,
Ricardo Macarron
2
,
Wendy C Rowan
2
,
William J Cairns
2
,
Jan Roger
2
,
Joanna Betts
2
,
Soren Beinke
3
,
Klio Maratou
2
Affiliations
1
Target Sciences, GlaxoSmithKline Research and Development, Stevenage, UK radu.a.rapiteanu@gsk.com.
2
Target Sciences, GlaxoSmithKline Research and Development, Stevenage, UK.
3
Refractory Respiratory Inflammation DPU, GlaxoSmithKline Research and Development, Stevenage, UK.
PMID:
32060058
DOI:
10.1183/13993003.00950-2019
No abstract available
Publication types
Letter
MeSH terms
Bronchi / cytology
Cell Culture Techniques / methods
Cell Differentiation / genetics*
Epithelial Cells / metabolism*
Gene Editing / methods*
Humans
Respiratory Mucosa / metabolism*